Insulin Aspart Injection, Solution
Product Images NDC 73070-102

Product Visual Gallery

This gallery contains 47 technical images submitted to the FDA as part of the official labeling for Insulin Aspart (NDC 73070-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Formula (Image 01)

Chemical structure diagram showing the amino acid sequence of the A-chain and B-chain of insulin aspart, with labels for each amino acid and disulfide bond connections between cysteine residues.*

FDA Label Image

Figure 1 (Image 02)

A line graph showing serum glucose levels (mg/dL) plotted against time (hours) over a 6-hour period, with two curves representing different conditions or treatments. The y-axis ranges from 50 to 300 mg/dL, and the x-axis spans from 0 to 6 hours.*

FDA Label Image

Figure 3 (Image 03)

A line graph depicting mean blood glucose levels (mg/dL) over time (minutes) for insulin aspart. The x-axis shows time points before and after an event labeled 'R', with a break indicated by slashes. The y-axis ranges from 0 to 180 mg/dL. The graph includes error bars representing variability around the mean values.*

FDA Label Image

Figure 4 (Image 04)

A line graph depicting free serum insulin (mU/L) over time (hours). The chart shows two lines illustrating changes in insulin concentration from 0 to 6 hours, with one line peaking sharply near the beginning and the other maintaining a steadier, lower level throughout.*

FDA Label Image

Overview (FlexPen)

An illustration of the Insulin Aspart FlexPen, a prefilled injection pen device. The diagram labels components including the pen cap, rubber stopper, cartridge, cartridge scale, pointer, dose selector, and push-button. The pen is depicted as a handheld device used for subcutaneous or intravenous administration.*

FDA Label Image

Novifine And Novofine Plus (Overview)

An instructional diagram showing the parts of NovoFine and NovoFine Plus injection needles. Each needle type is broken down into four components: big outer needle cap, inner needle cap, needle, and protective tab. The illustration helps differentiate the needle assembly between the two types.*

FDA Label Image

Vial Figure (Image 07)

An illustration showing a vial with a tamper-resistant cap and a rubber stopper located under the cap. The diagram is labeled to identify these vial components clearly.*

FDA Label Image

Hand And Vial Figure (Image 08)

A black-and-white line drawing illustration showing a hand holding a small vial, likely representing an injection vial for Insulin Aspart solution. The hand is positioned to grip the vial between the thumb and fingers, highlighting how to hold the vial properly.*

FDA Label Image

Figure A And Figure B (Image 09)

An instructional illustration showing a hand removing the cap from a vial, demonstrated in two steps labeled Figure A and Figure B. The image appears to guide on how to open the vial before use.*

FDA Label Image

Figure C (Image 10)

An instructional illustration showing the preparation of an insulin injection. One hand holds a vial upside down while the other hand pulls fluid into a syringe. A close-up inset highlights the syringe with measured solution. This diagram demonstrates the steps to draw insulin aspart 100 IU/mL from a vial for subcutaneous or intravenous injection.*

FDA Label Image

Figure D (Image 11)

An instructional illustration labeled "Figure D" showing a person holding a syringe and a vial, demonstrating the process of drawing medication from the vial into the syringe. The image depicts hands manipulating the syringe and vial with the syringe needle inserted into the vial.*

FDA Label Image

Figure E (Image 12)

An instructional illustration labeled 'Figure E' showing how to connect or draw medication from a vial using a syringe. The image depicts a hand inserting a needle into the vial's rubber stopper with an arrow indicating the motion. This likely relates to preparation of insulin aspart injection solution.*

FDA Label Image

Figure F (Image 13)

Instructional illustration showing a hand holding a vial upside down while drawing liquid into a syringe, indicated by a downward arrow. The image demonstrates part of the process for preparing an injection, relevant for insulin aspart injection, solution.*

FDA Label Image

Figure G (Image 14)

An instructional illustration showing the preparation of a dose using a vial and syringe. One hand holds the vial upside down while the other hand attaches or draws liquid into the syringe. The image is likely related to subcutaneous or intravenous administration of an injectable solution.*

FDA Label Image

Figure H (Image 15)

An instructional diagram showing the preparation of an insulin aspart injection solution. It depicts a hand holding a vial upside down while drawing the solution into a syringe from the vial. An inset focuses on the syringe with visible liquid inside, illustrating the correct technique for intravenous or subcutaneous administration preparation.*

FDA Label Image

Figure I (Image 16)

An illustration depicting the proper technique for drawing a liquid medication with a syringe from a vial held in one hand, as indicated by the arrow showing motion. This instructional image relates to medication preparation for injection.*

FDA Label Image

Fig. J (Image 17)

An instructional diagram showing front and back views of a human torso and legs. Highlighted areas indicate recommended injection sites for insulin aspart, including the abdomen, upper outer thigh, and upper buttocks.*

FDA Label Image

Figure K (Image 18)

An instructional illustration labeled Figure K, depicting two hands preparing an injection. One hand holds a vial or syringe while the other hand is pulling back the plunger, suggesting the drawing of medication into the syringe. No text or product branding is visible in the image.*

FDA Label Image

Figure L (Image 19)

An instructional illustration showing a hand injecting insulin aspart solution into the skin using a syringe. The image demonstrates the action of injecting subcutaneously with an arrow indicating upward movement of the syringe plunger.*

FDA Label Image

Novotwist Needle (Image 20)

An instructional diagram showing the components of the NovoTwist injection needle assembly for Insulin Aspart. The diagram labels the big outer needle cap, inner needle cap, needle, and protective tab, illustrating their arrangement and use for the subcutaneous injection solution.*

FDA Label Image

Pull Off The Pen Cap (Image 21)

An instructional diagram showing a hand pressing and sliding a blue and white insulin pen cap, indicating the step to remove the cap from the insulin pen prior to use.*

FDA Label Image

Turn The Dose Selector To Select 2 Units. (Image 22)

An instructional illustration showing a close-up of a blue insulin aspart injection pen being dialed to select a dose. The dial's window shows a setting of 2 units, indicated by an arrow turning the dosage selector on the pen, demonstrating dose adjustment for subcutaneous or intravenous injection.*

FDA Label Image

Tap The Cartridge Gently (Image 23)

An instructional illustration showing a finger pressing the plunger of a syringe. The syringe is positioned vertically, with a small upper arm visible nearby. This image suggests the action of injecting or preparing an injection.*

FDA Label Image

Keep The Needle Pointing Upwards (Image 24)

An instructional illustration showing a hand holding an insulin pen, with the thumb pressing on the top and an arrow pointing upward, indicating how to prepare or prime the insulin aspart injection pen before administration.*

FDA Label Image

Turn The Dose Selector To The Number Of Units You Need To Inject (Image 25)

An instructional illustration showing how to select the dose on an insulin pen injector. The image depicts a hand adjusting the dial on the pen, with visual examples of a 5-unit and a 24-unit selection displayed on the dose window.*

FDA Label Image

Giving The Injection (Image 26)

An instructional illustration showing a hand holding a vial with a cap being pulled off or pushed down, indicated by a downward arrow. The vial label includes partially visible text and a symbol resembling 'Q=' with a swirl design, suggesting a step in the preparation or usage of the insulin aspart injection.*

FDA Label Image

Making Sure That The Full Dose Has Been Given (Image 27)

Illustration showing a syringe needle inserted into the skin at an angle, depicting the subcutaneous injection technique for administering an injection solution.*

FDA Label Image

Put The Pen Cap On (Image 28)

An instructional illustration showing a close-up of a hand holding and pressing the cap of an insulin pen, with an arrow indicating the direction to pull or remove the cap. The pen is blue and white with a clear window, likely indicating the dose setting area.*

FDA Label Image

Figure A Penfill Cartridge And Needle Components. (Image 41)

Illustration of components for NovoFine, NovoFine Plus, and NovoTwist needles, including outer needle cap, inner needle cap, needle, and paper tab. Also shows parts of a PenFill cartridge compatible insulin delivery device, such as pen cap, cartridge holder, dose pointer, dose counter, dose selector/button, threaded end for needle attachment, colored band, and rubber plunger, with an example 3 mL PenFill cartridge.*

FDA Label Image

Diagram B: Attaching The Needle. (Image 43)

An instructional illustration showing steps to assemble or prepare the NovoFine and NovoTwist insulin injection devices. It depicts close-up views of hands manipulating components, indicating a twisting or locking action required for proper device setup.*

FDA Label Image

Diagram C: Pull Off The Outer Needle Cap. (Image 44)

An instructional illustration showing how to attach a NovoFine or NovoFine Plus needle and a NovoTwist needle to a syringe or pen device. The diagrams depict hand positioning and the direction to connect the needle securely.*

FDA Label Image

Diagram D: Pull Off Inner Needle Cap. (Image 45)

Instructional illustration showing the method for removing the cap from a NovoFine or NovoFine Plus needle (push and pull method) and from a NovoTwist needle (twisting motion). The image depicts a hand gripping the needle cap and the direction of removal.*

FDA Label Image

Figure B: Check The Penfill Cartridge. (Image 53)

An instructional illustration showing a hand holding a pen-like injection device with a focus on the threaded end of the device, relevant to the administration of Insulin Aspart injection solution.*

FDA Label Image

Vial Carton (Image 54)

The image shows a flat layout of the Insulin Aspart injection carton label by Novo Nordisk Pharma, Inc. It features the proprietary name Insulin Aspart 100 units/mL in a 10 mL multi-dose vial. The label includes manufacturer information, distribution details, barcode, storage warnings, and patent information. The color scheme includes white with blue and orange elements.*

FDA Label Image

Penfill Carton (Image 55)

Packaging label for Insulin Aspart PenFill injection by Novo Nordisk Pharma, Inc. It contains 3 mL cartridges with 100 units/mL strength. The label specifies use for single patients and notes compatibility with Novo Nordisk 3 mL PenFill cartridge delivery devices. It includes storage instructions and barcode information.*

FDA Label Image

Flexpen Carton (Image 56)

Packaging label for Insulin Aspart FlexPen Prefilled Syringe 100 units/mL injection solution by Novo Nordisk Pharma, Inc. The label shows an image of the orange and blue FlexPen injector. It includes usage warnings, barcode, and dosage information for subcutaneous or intravenous administration.*

FDA Label Image

Figure C: Insert The Cartridge. (Image 58)

An instructional diagram showing two hands preparing an injection device. One hand holds a pen-like injector, and the other hand holds a syringe, with an arrow indicating the direction to connect or insert the syringe into the injector device.*

FDA Label Image

Figure D: Pust The Needle Straight On. (Image 59)

An instructional illustration comparing two injection techniques labeled 'NovoFine/NovoFine Plus' and 'NovoTwist'. Both show a hand holding a syringe and preparing it for injection, with arrows indicating the motion or steps involved in using each injection system.*

FDA Label Image

Figure E: Pull Off The Outer Needle Cap. (Image 60)

An instructional illustration showing how to attach NovoFine and NovoTwist needle tips to a syringe or pen device. The image depicts hand positioning and directional arrows indicating the proper twisting or pushing motion for secure attachment of the needle tips.*

FDA Label Image

Figure F: Pull Off The Inner Needle Cap. (Image 61)

Illustration showing the use of NovoFine, NovoFine Plus, and NovoTwist needles for insulin injection. The diagram demonstrates connecting the needles to the syringe or pen device, highlighting proper attachment technique.*

FDA Label Image

Figure I: Injection Sites (Image 62)

An illustration diagram showing recommended injection sites for Insulin Aspart injection solution. The labeled body areas include upper arms, abdomen, upper thighs, and buttocks as places to inject subcutaneously.*

FDA Label Image

Figure J: Count Slowly. (Image 63)

An instructional illustration showing a hand holding an insulin pen injection device inserted into a forearm. A speech bubble instructs to count slowly "1-2-3-4-5-6" while administering the injection.*

FDA Label Image

Figure K: Lead The Needle Tip Into The Outer Cap. (Image 65)

An instructional illustration showing the proper connection of a needle or device to a syringe or pen injector. The image includes two arrows indicating the assembly direction for attaching the needle securely to the injection device, relevant for preparing insulin aspart injection.*

FDA Label Image

Figure L: Unscrew The Needle. (Image 66)

An instructional illustration showing hands holding a cartridge holder for an injection pen. The image demonstrates rotating the cartridge holder upwards for preparation or removal. It is related to patient use of an injection device, likely for insulin aspart.*

FDA Label Image

Figure M: Put The Cap On The Device. (Image 67)

An instructional illustration showing a hand holding an insulin pen with a needle attached, indicating the step to press the pen downwards to inject the solution. The image demonstrates proper technique for using an insulin pen injection device.*

FDA Label Image

Figure G: Insulin Squirts. (Image 68)

Insulin Aspart 100 IU/mL injection solution in a vial, with a visible needle attached, labeled by Novo Nordisk Pharma, Inc. The image shows a medical vial designed for intravenous or subcutaneous administration.*

FDA Label Image

Figure H: Select Your Dose. (Image 69)

An illustration showing the dose counter, dose selector, and dose pointer on an insulin pen device, demonstrating how to select a dose of 12 units. The image includes hands adjusting the dose selector and an arrow indicating the rotation direction.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.